×
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
S&P 500   3,911.74 (+3.06%)
DOW   31,500.68 (+2.68%)
QQQ   294.61 (+3.43%)
AAPL   141.66 (+2.45%)
MSFT   267.70 (+3.41%)
META   170.16 (+7.19%)
GOOGL   2,359.50 (+5.11%)
AMZN   116.46 (+3.58%)
TSLA   737.12 (+4.52%)
NVDA   171.26 (+5.55%)
NIO   24.08 (+4.47%)
BABA   117.62 (+4.91%)
AMD   87.08 (+5.64%)
MU   58.44 (+3.95%)
CGC   3.77 (+4.72%)
T   20.99 (+1.84%)
GE   67.08 (+4.70%)
F   12.01 (+3.89%)
DIS   97.78 (+3.69%)
AMC   12.47 (+3.49%)
PFE   51.59 (+2.99%)
PYPL   77.68 (+5.24%)
NFLX   190.85 (+5.03%)
NASDAQ:ACLS

Axcelis Technologies Stock Forecast, Price & News

$58.20
+4.46 (+8.30%)
(As of 06/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$54.19
$58.24
50-Day Range
$51.63
$64.22
52-Week Range
$33.36
$83.74
Volume
709,362 shs
Average Volume
465,362 shs
Market Capitalization
$1.92 billion
P/E Ratio
16.03
Dividend Yield
N/A
Price Target
$75.75
30 days | 90 days | 365 days | Advanced Chart

Receive ACLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Axcelis Technologies and its competitors with MarketBeat's FREE daily newsletter.

ACLS Stock Forecast (MarketRank)

Overall MarketRank

2.39 out of 5 stars

Computer And Technology Sector

256th out of 923 stocks

Special Industry Machinery, Not Elsewhere Classified Industry

7th out of 19 stocks

Analyst Opinion: 3.5Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
Axcelis Technologies logo

About Axcelis Technologies (NASDAQ:ACLS)

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.

ACLS Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Special industry machinery, not elsewhere classified
Sub-Industry
Semiconductor Equipment
Current Symbol
NASDAQ:ACLS
CUSIP
05454010
Employees
1,195
Year Founded
1978

Company Calendar

Last Earnings
5/04/2022
Today
6/24/2022
Next Earnings (Estimated)
8/03/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$75.75
High Stock Price Forecast
$80.00
Low Stock Price Forecast
$67.00
Forecasted Upside/Downside
+30.2%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
4 Analysts

Profitability

Net Income
$98.65 million
Pretax Margin
20.20%

Debt

Sales & Book Value

Annual Sales
$662.43 million
Cash Flow
$3.59 per share
Book Value
$16.18 per share

Miscellaneous

Free Float
32,310,000
Market Cap
$1.92 billion
Optionable
Optionable
Beta
1.66

Social Links















Axcelis Technologies Frequently Asked Questions

Should I buy or sell Axcelis Technologies stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Axcelis Technologies in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Axcelis Technologies stock.
View analyst ratings for Axcelis Technologies
or view top-rated stocks.

What is Axcelis Technologies' stock price forecast for 2022?

4 brokers have issued 1 year price objectives for Axcelis Technologies' shares. Their ACLS stock forecasts range from $67.00 to $80.00. On average, they expect Axcelis Technologies' stock price to reach $75.75 in the next year. This suggests a possible upside of 30.2% from the stock's current price.
View analysts' price targets for Axcelis Technologies
or view top-rated stocks among Wall Street analysts.

How has Axcelis Technologies' stock price performed in 2022?

Axcelis Technologies' stock was trading at $74.56 on January 1st, 2022. Since then, ACLS stock has decreased by 21.9% and is now trading at $58.20.
View the best growth stocks for 2022 here
.

When is Axcelis Technologies' next earnings date?

Axcelis Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Axcelis Technologies
.

How were Axcelis Technologies' earnings last quarter?

Axcelis Technologies, Inc. (NASDAQ:ACLS) released its earnings results on Wednesday, May, 4th. The semiconductor company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $0.92 by $0.30. The semiconductor company had revenue of $203.60 million for the quarter, compared to analysts' expectations of $193.12 million. Axcelis Technologies had a net margin of 16.88% and a trailing twelve-month return on equity of 23.53%. The firm's quarterly revenue was up 53.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.48 EPS.
View Axcelis Technologies' earnings history
.

What guidance has Axcelis Technologies issued on next quarter's earnings?

Axcelis Technologies updated its second quarter 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share (EPS) guidance of $1.00-$1.00 for the period, compared to the consensus estimate of $0.97. The company issued revenue guidance of $205.00 million-$215.00 million, compared to the consensus revenue estimate of $201.53 million.

What are Wall Street analysts saying about Axcelis Technologies stock?

Here are some recent quotes from research analysts about Axcelis Technologies stock:
  • 1. The company introduced two new target business models at its analyst day for ~$850M and $1B in annual revenue, which are targeted to drive EPS of ~$4.25 and ~$5.60 respectively, Schwab tells investors in a research note. Schwab remains very encouraged by the company's newly outlined target models for multiyear growth and material earnings leverage to targeted EPS levels more than double 2021 expectations at the company's $1B target model. " (12/10/2021)
  • 2. The analyst cites the company's investor day presentation that featured an update on its business and introduced two new target models, raising its near-term revenue guidance outlook to $850. Bolton adds that the strong growth in the implant-intensive mature market segment and overall WFE growth have increased the ion implant total addressable market to about $2B. " (12/10/2021)

Who are Axcelis Technologies' key executives?

Axcelis Technologies' management team includes the following people:

What is Mary G. Puma's approval rating as Axcelis Technologies' CEO?

45 employees have rated Axcelis Technologies CEO Mary G. Puma on Glassdoor.com. Mary G. Puma has an approval rating of 38% among Axcelis Technologies' employees. This puts Mary G. Puma in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Axcelis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcelis Technologies investors own include NVIDIA (NVDA), Micron Technology (MU), Advanced Micro Devices (AMD), Applied Materials (AMAT), Alibaba Group (BABA), Bank of America (BAC), AbbVie (ABBV), Adobe (ADBE), AT&T (T) and Netflix (NFLX).

What is Axcelis Technologies' stock symbol?

Axcelis Technologies trades on the NASDAQ under the ticker symbol "ACLS."

Who are Axcelis Technologies' major shareholders?

Axcelis Technologies' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.32%), Vanguard Group Inc. (8.30%), Primecap Management Co. CA (5.86%), Dimensional Fund Advisors LP (4.72%), Wellington Management Group LLP (3.41%) and State Street Corp (3.28%). Company insiders that own Axcelis Technologies stock include Arthur L George Jr, Dennis Thomas St, Douglas A Lawson, Douglas A Lawson, John E Aldeborgh, John T Kurtzweil, Jorge Titinger, Joseph P Keithley, Joseph P Keithley, Kevin J Brewer, Kevin J Brewer, Lynnette C Fallon, Lynnette C Fallon, Mary G Puma, Mary G Puma, R John Fletcher, Russell Low, William J Bintz and William J Bintz.
View institutional ownership trends for Axcelis Technologies
.

Which institutional investors are selling Axcelis Technologies stock?

ACLS stock was sold by a variety of institutional investors in the last quarter, including Primecap Management Co. CA, Russell Investments Group Ltd., Wellington Management Group LLP, Arrowstreet Capital Limited Partnership, Invesco Ltd., Royce & Associates LP, The Manufacturers Life Insurance Company , and Rice Hall James & Associates LLC. Company insiders that have sold Axcelis Technologies company stock in the last two years include Arthur L George Jr, Dennis Thomas St, Douglas A Lawson, John T Kurtzweil, Jorge Titinger, Joseph P Keithley, Kevin J Brewer, Lynnette C Fallon, Mary G Puma, R John Fletcher, Russell Low, and William J Bintz.
View insider buying and selling activity for Axcelis Technologies
or view top insider-selling stocks.

Which institutional investors are buying Axcelis Technologies stock?

ACLS stock was purchased by a variety of institutional investors in the last quarter, including Great Lakes Advisors LLC, Assenagon Asset Management S.A., Prudential Financial Inc., Goldman Sachs Group Inc., Pacer Advisors Inc., Penserra Capital Management LLC, Vanguard Group Inc., and Charles Schwab Investment Management Inc..
View insider buying and selling activity for Axcelis Technologies
or or view top insider-buying stocks.

How do I buy shares of Axcelis Technologies?

Shares of ACLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axcelis Technologies' stock price today?

One share of ACLS stock can currently be purchased for approximately $58.20.

How much money does Axcelis Technologies make?

Axcelis Technologies (NASDAQ:ACLS) has a market capitalization of $1.92 billion and generates $662.43 million in revenue each year. The semiconductor company earns $98.65 million in net income (profit) each year or $3.629990 on an earnings per share basis.

How many employees does Axcelis Technologies have?

Axcelis Technologies employs 1,195 workers across the globe.

When was Axcelis Technologies founded?

Axcelis Technologies was founded in 1978.

How can I contact Axcelis Technologies?

Axcelis Technologies' mailing address is 108 CHERRY HILL DRIVE, BEVERLY MA, 01915. The official website for Axcelis Technologies is www.axcelis.com. The semiconductor company can be reached via phone at (978) 787-4000, via email at [email protected], or via fax at 978-787-3000.

This page (NASDAQ:ACLS) was last updated on 6/24/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.